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We are very pleased with the way the journal’s transition to a different model of 
publication has progressed. The publication of individual papers and their retrospective 
collation within whole issues maximizes the benefits for an online open access journal 
avoiding the often tortuous wait for publication in solely paper journals without 
compromising on the quality of peer review. 
 
I am delighted to now present volume 5, issue 2 which is non-themed and comprises five 
articles and three book reviews. Commencing with Vandenberg & Boon’s paper entitled 
Anticipating emerging genomics technologies: The role of patents and publication for 
research and policy strategies, we begin with the methodological problems of explicating 
and anticipating the emergence of new areas in the biosciences. More specifically the 
authors are concerned to identify hot spots in pharmacogenomics and nutrigenomics. 
Drawing upon patent and publication search strategies to discover such hot spots – 
methods familiar to several of us in the ESRC genomics network – the authors are able to 
characterize where and in which substantive domains such research is emerging. A 
discussion on the benefits and limitations of their methods and their impact on policy 
strategies concludes the paper. The second paper by Thomas Lemke, entitled “A slap in 
the face”: An exploratory study of genetic discrimination in Germany, contributes to 
ongoing debates around understandings and experiences of genetic discrimination. The 
focus is on those affected by (the risk of) Huntington’s Disease (HD). Lemke chooses to 
focus on HD due to the uncertainty around those ‘persons at risk’, (every child of a 
person bearing the mutation has a 50 per cent probability of receiving the allele in 
question), the availability of a predictive genetic test for the condition, and already 
established evidence for discrimination against carriers or potential carriers of the 
condition. Lemke draws upon cases from his own research to illustrate the complex 
dimensions of what we refer to as ‘discrimination’ and to argue specifically for the 
importance of interactional as well as institutionalized structural discrimination to be 
recognized by such research and policy. The third paper in this issue by Theo 
Papaioannou, entitled The impact of new life sciences innovation on political theories of 
justice, makes the argument that new life sciences innovation and their impact on 
understandings of ‘human nature’ call into question the adequacy of liberal theories of 
justice. Papaioannou critically engages with the work of Rawls, Nozick and Sen to stake 
a claim over how understandings of justice could, according to his argument, be better 
conceptualized to address the way the life sciences alter our exposure to both chance and 
choice.   
 
Lyn Turney’s Understanding the genetically at risk: clinical, psychological and social 
approaches explores the way in which genetic tests for a wide range of cancers have 
opened up the possibility for various prophylactic treatments in order to address risk. 
Turney explores the complex situation in which the ‘genetically at risk’ are placed, due 
not only to the uncertainty of whether they might develop a particular cancer but also that 
of the prophylactic treatment itself that may include surgery to remove at-risk body parts, 
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treatment with cancer drugs, medical surveillance strategies, self-surveillance and 
changes in lifestyle. She concludes with an argument for policy reflexivity linked to 
social science research embedded in an exploration of the cultural, personal, historical 
and social factors that contribute to the ways in which the genetically at risk negotiate 
knowledge about genetic risk 
  
The final paper of the issue by Elina Hemminki and colleagues looks at Finnish people's 
attitudes towards biomedical research and its sponsorship. This paper reports on a 
survey in Finland that explores various orientations toward blood sample donation, 
willingness to take part in Finnish versus international research and degrees of trust in 
public versus privately conducted clinical research.  
 
The issue is completed by three review essays of The Art and Politics of Science, by 
Harold Varmus, When Experiments Travel, by Adriana Petryna, and Leonardo's Choice - 
Genetic Technologies and Animals, edited by Carol Gigliotti. We thank all our 
contributors, reviewers and, of course, our managing editor Claire Packman.  
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